Drug Type Diagnostic radiopharmaceuticals |
Synonyms |
Target |
Mechanism oxMIF inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | AT | 21 Mar 2024 | |
Solid tumor | Preclinical | AT | 24 May 2023 |